April 9, 20215:55 PM UTCLast Updated ago

White House says J&J remains committed to meeting its COVID vaccine contract

1 minute read

Register now for FREE unlimited access to Reuters.com

WASHINGTON, April 9 (Reuters) - The Biden administration says Johnson & Johnson (JNJ.N) remains committed to meeting its COVID-19 vaccine contract of delivering close to 100 million doses by the end of May, White House press secretary Jen Psaki said on Friday.

Register now for FREE unlimited access to Reuters.com

Reporting By Steve Holland and Jarrett Renshaw Editing by Chris Reese

Our Standards: The Thomson Reuters Trust Principles.

Healthcare & Pharmaceuticals

FDA chief backs alternate method for injecting Bavarian Nordic's monkeypox shot, article with imageWorld · August 11, 2022
The U.S. Food and Drug Administration chief on Thursday defended a plan to administer Bavarian Nordic's monkeypox shot intradermally after the company raised doubts about the safety of the method, citing a lack of data.
Future of HealthBiotech stocks pin bounce back hopes on M&A boost, article with imageAugust 12, 2022
Future of HealthLong COVID risk up for unvaccinated children; at-home antibody test shows promise, article with imageAugust 11, 2022
Future of HealthRoche gets U.S. approval for flu drug for children aged 5 and over, article with imageAugust 12, 2022
WorldIn Caracas, equine therapy offers hope for disabled kids from low-income families, article with galleryAugust 12, 2022

White House says J&J remains committed to meeting its COVID vaccine contract

Register now for FREE unlimited access to Reuters.com

Register now for FREE unlimited access to Reuters.com

Healthcare & Pharmaceuticals

Thomson Reuters Products

Refinitiv Products